Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease

Caitlin E. Cox

December 18, 2025

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

Shelley Wood

May 30, 2023

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Daily News

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Michael O'Riordan

December 09, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Michael O'Riordan

February 20, 2018

Presentation

CABG vs PCI in Diabetic Patients with Left Ventricular Dysfunction

February 20, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Conference News AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Jason Kahn

November 04, 2012

Advertisement

Cardiac Damage Starts Early When There’s Family History of Cardiometabolic Disease

November 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for May 2024

February 2024 Dispatch for the CV Team

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

November 2021 News Roundup

June 2021 News Roundup

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

CABG vs PCI in Diabetic Patients with Left Ventricular Dysfunction

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

DES Outcomes Vary by Diabetes Status, Lesion Complexity

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content